List of Excipients in API bosentan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing bosentan
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| CoTherix Inc | BOSENTAN | bosentan | 10148-625 | ETHYLCELLULOSE | |
| CoTherix Inc | BOSENTAN | bosentan | 10148-625 | FERRIC OXIDE RED | |
| CoTherix Inc | BOSENTAN | bosentan | 10148-625 | FERRIC OXIDE YELLOW | |
| CoTherix Inc | BOSENTAN | bosentan | 10148-625 | GLYCERYL DIBEHENATE | |
| CoTherix Inc | BOSENTAN | bosentan | 10148-625 | HYPROMELLOSE | |
| CoTherix Inc | BOSENTAN | bosentan | 10148-625 | MAGNESIUM STEARATE | |
| CoTherix Inc | BOSENTAN | bosentan | 10148-625 | POVIDONE K90 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing bosentan
Detailed excipient profiles for bosentan
Excipient focus: ACESULFAME POTASSIUM
bosentan drug variants containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing ACESULFAME POTASSIUM
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
bosentan drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing AMMONIA
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
bosentan drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
Excipient focus: ASPARTAME
bosentan drug variants containing ASPARTAME
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing ASPARTAME
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
bosentan drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
bosentan drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-386 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
bosentan drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| Lupin Pharmaceuticals Inc | bosentan | 68180-386 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
bosentan drug variants containing ETHYLCELLULOSE
bosentan drug variants not containing ETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Alvogen Inc | bosentan | 47781-270 |
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| Lupin Pharmaceuticals Inc | bosentan | 68180-386 |
| Zydus Pharmaceuticals USA Inc | bosentan | 68382-446 |
| >Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSES
bosentan drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-386 |
| Zydus Pharmaceuticals USA Inc | bosentan | 68382-446 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
bosentan drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
bosentan drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL BEHENATE/EICOSADIOATE
bosentan drug variants containing GLYCERYL BEHENATE/EICOSADIOATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | bosentan | 0591-2511 |
| Amneal Pharmaceuticals LLC | bosentan | 65162-873 |
| Cipla USA Inc | bosentan | 69097-377 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing GLYCERYL BEHENATE/EICOSADIOATE
Excipient focus: GLYCERYL DIBEHENATE
bosentan drug variants containing GLYCERYL DIBEHENATE
bosentan drug variants not containing GLYCERYL DIBEHENATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | bosentan | 0591-2511 |
| Alvogen Inc | bosentan | 47781-270 |
| Amneal Pharmaceuticals LLC | bosentan | 65162-873 |
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| Cipla USA Inc | bosentan | 69097-377 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
bosentan drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| CoTherix Inc | bosentan | 10148-625 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Amneal Pharmaceuticals LLC | bosentan | 65162-873 |
| Actelion Pharmaceuticals US Inc | bosentan | 66215-101 |
| Cipla USA Inc | bosentan | 69097-377 |
| Zydus Lifesciences Limited | bosentan | 70771-1017 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
bosentan drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
bosentan drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Alembic Pharmaceuticals Inc | bosentan | 62332-383 |
| Lupin Pharmaceuticals Inc | bosentan | 68180-386 |
| Zydus Pharmaceuticals USA Inc | bosentan | 68382-446 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| Amneal Pharmaceuticals LLC | bosentan | 65162-873 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
bosentan drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
bosentan drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: OLEIC ACID
bosentan drug variants containing OLEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing OLEIC ACID
Excipient focus: POLYETHYLENE GLYCOL
bosentan drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | bosentan | 47781-270 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYVINYL ALCOHOL
bosentan drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | bosentan | 47781-270 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
bosentan drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | bosentan | 47781-270 |
| Amneal Pharmaceuticals LLC | bosentan | 65162-873 |
| Lupin Pharmaceuticals Inc | bosentan | 68180-386 |
| Zydus Pharmaceuticals USA Inc | bosentan | 68382-446 |
| Zydus Lifesciences Limited | bosentan | 70771-1017 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
bosentan drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Alembic Pharmaceuticals Inc | bosentan | 62332-383 |
| Cipla USA Inc | bosentan | 69097-377 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| Amneal Pharmaceuticals LLC | bosentan | 65162-873 |
| Actelion Pharmaceuticals US Inc | bosentan | 66215-101 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
bosentan drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| Actelion Pharmaceuticals US Inc | bosentan | 66215-101 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing POVIDONE K90
Excipient focus: SILICON DIOXIDE
bosentan drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
bosentan drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-386 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
bosentan drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | bosentan | 65162-873 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
bosentan drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals LLC | bosentan | 65162-873 |
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| Cipla USA Inc | bosentan | 69097-377 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE B POTATO
bosentan drug variants containing SODIUM STARCH GLYCOLATE TYPE B POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | bosentan | 69097-377 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing SODIUM STARCH GLYCOLATE TYPE B POTATO
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
bosentan drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| Amneal Pharmaceuticals LLC | bosentan | 65162-873 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Alembic Pharmaceuticals Inc | bosentan | 62332-383 |
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, PREGELATINIZED CORN
bosentan drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Alembic Pharmaceuticals Inc | bosentan | 62332-383 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| Amneal Pharmaceuticals LLC | bosentan | 65162-873 |
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
bosentan drug variants containing TALC
bosentan drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | bosentan | 0591-2511 |
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
bosentan drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| West-Ward Pharmaceuticals Corp | bosentan | 0054-0520 |
| Actavis Pharma Inc | bosentan | 0591-2511 |
| CoTherix Inc | bosentan | 10148-625 |
| Alembic Pharmaceuticals Limited | bosentan | 46708-383 |
| Sun Pharmaceutical Industries Inc | bosentan | 47335-038 |
| Alvogen Inc | bosentan | 47781-270 |
| Par Pharmaceutical Inc | bosentan | 49884-058 |
| >Company | >Ingredient | >NDC |
bosentan drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
bosentan drug variants containing TRIACETIN
bosentan drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Alvogen Inc | bosentan | 47781-270 |
| Lupin Pharmaceuticals Inc | bosentan | 68180-340 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
